Department of Gynecologic Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
Minerva Med. 2009 Oct;100(5):415-20.
The use of PET/CT has been advocated in the management of ovarian cancer as a diagnostic strategy to assist in patient management. To date, data in the peer reviewed literature support the argument that findings on PET/CT reveal evidence of the extent of disease and may be helpful in documenting disease recurrence. However, it remains to be determined through the conduct of phase 3 randomized trials if the information generated will be useful in predicting benefit of a management plan specifically selected based on the results of this expensive radiographic procedure.
正电子发射断层扫描/计算机断层扫描（PET/CT）在卵巢癌的管理中被提倡作为一种诊断策略，以协助患者管理。迄今为止，同行评议文献中的数据支持这样的观点，即 PET/CT 的发现揭示了疾病的范围，并可能有助于记录疾病的复发。然而，通过进行 3 期随机试验，仍然需要确定生成的信息是否有助于预测管理计划的获益，具体来说，是基于这一昂贵的影像学检查结果选择的管理计划。
